A new trend gaining popularity among people trying to lose weight is microdosing the diabetes medication Ozempic. Experts ...

Ozempic, Wegovy and Mounjaro, all GLP-1 anti-obesity medications, may offer health benefits beyond weight loss. Studies show ...

Some eye doctors were noticing a trend among patients that researchers in Europe now believe has been well demonstrated with ...

Malaysia is grappling with a shortage of Ozempic, a diabetes medication, as a global trend of using the drug for weight loss ...

In 1987, fewer than one in five American adults were obese, and by 1999, obesity was responsible for more than 300,000 excess ...

A new study finds semaglutide is linked to an increased risk of vision loss associated with a rare eye condition, but cases ...

Ozempic has fast become a household name. In addition to helping people with diabetes manage their blood sugar levels, this ...

“We expect patients to lose anywhere from 5 to 12 per cent of their total body weight,” he adds. However, not all who have diabetes will be prescribed Ozempic, notes Dr Tan. As a first-line ...

In recent developments, health officials in Europe have launched an investigation into the popular weight loss drug Ozempic, ...

There is an increased demand from non-diabetic individuals due to its weight loss effects. Read more at straitstimes.com.

KUALA LUMPUR, Dec 30 – The Malaysian Pharmacists Society (MPS) has reportedly raised concerns over a shortage of Ozempic, a ...

Learn how two studies from Denmark expand upon earlier U.S. work that first linked the medication with the eye disease.